Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Gabapentin on Prevention of Delirium After Coronary Artery Bypass Surgery
IRCT20200306046706N1Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of gabapentin in delirium, coronary arteriosclerosis and postoperative delirium (POD), sponsored by Shahid Sadoughi University of Medical Sciences. Started Feb 2019; status: completed.
02
Drugs
gabapentin
03
Conditions
deliriumcoronary arteriosclerosispostoperative delirium (POD)
Beyond the preview
Go deeper on IRCT20200306046706N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200306046706N1.